Key statistics
As of last trade Collegium Pharmaceutical Inc (354:STU) traded at 29.60, -21.28% below its 52-week high of 37.60, set on Oct 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.80 |
---|---|
High | 31.80 |
Low | 29.60 |
Bid | 29.60 |
Offer | 30.80 |
Previous close | 32.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 32.21m |
Free float | 31.79m |
P/E (TTM) | 14.00 |
Market cap | 1.04bn USD |
EPS (TTM) | 2.30 USD |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Announcements
- Collegium Reports Record Third Quarter 2024 Financial Results
- Collegium Appoints Vikram Karnani as Chief Executive Officer
- Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
- Collegium Completes Acquisition of Ironshore Therapeutics
- Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
- Collegium Reports Second Quarter 2024 Financial Results
- Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
- Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
- Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
More ▼